Litigation Details for Galderma Laboratories LP v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Galderma Laboratories LP v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-12-10 |
| Court | District Court, D. Delaware | Date Terminated | 2020-03-12 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | Plaintiff | Referred To | |
| Parties | NESTLE SKIN HEALTH S.A. | ||
| Patents | 6,133,310; 7,550,440; 8,080,530; 8,093,219; 8,415,311; 8,470,788; 8,815,816; 9,089,587; 9,233,117; 9,233,118; 9,782,425 | ||
| Attorneys | Kelly P. Chen | ||
| Firms | Shaw Keller LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Galderma Laboratories LP v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Galderma Laboratories LP v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-04-21 | 1 | Exhibit(s) C - US Patent No. 9,089,587 | US Patent No. 8,362,069, # 2 Exhibit(s) B - US Patent No. 8,815,816, # 3 Exhibit(s) C - US Patent No.…9,089,587, # 4 Exhibit(s) D - US Patent No. 9,233,117, # 5 Exhibit(s) E - US Patent No. 9,233,118, # 6 Cover …2017 12 March 2020 1:17-cv-01783 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| 2018-09-07 | 124 | argues for a construction drawn from U.S . Patent No . 6,133,310 ("Parks"), which is incorporated…six patents from three patent families against Defendant. (D.I. 110 at 1). The ' 587 Patent, the…the ' 117 Patent, the ' 118 Patent, and the '425 Patent are members of the Jacovella …history of the '249 Patent, a patent extrinsic to the ' 069 Patent, provides at least some support…of multiple terms in U.S. Patent Nos. 8,815,816 (the "' 816 Patent"), 8,362,069 (the " | External link to document | |
| 2018-09-17 | 128 | of U.S. Patent No. 8,815,816 (the “’816 Patent”), as well as Claims 7 and 13 of U.S. Patent No. 8,362,069…, and IV be entered as to U.S. Patent No. 8,815,816, and U.S. Patent No. 8,362,069, as set forth in the…8,362,069 (the “’069 Patent”). Each of the asserted dependent claims in the ’816 Patent depend from independent…; and the asserted dependent claims in the ’069 Patent depend (directly or indirectly) from independent…”); WHEREAS Claims 2 and 11 of the ’816 Patent require, among other things, “a mixture of solvents | External link to document | |
| 2019-01-16 | 190 | Betensky, Ph.D. on the Invalidity of U.S. Patent Nos. 9,089,587, 9,233,117, and 9,233,118; 2) Opening Expert…Gallo M.D., Ph.D. on the Invalidity of U.S. Patent Nos. 9,089,587, 9,233,117, and 9,233,118; 3) Expert Report…Todd Plott, M.D. on the Invalidity of U.S. Patent Nos. 9,089,587, 9,233,117, and 9,233,118 filed by Teva …2017 12 March 2020 1:17-cv-01783 830 Patent Plaintiff District Court, D. Delaware | External link to document | |
| 2019-02-19 | 192 | Todd Plott, M.D. on the Invalidity of U.S. Patent Nos. 9,089,587, 9,233,117, and 9,233,118 3) Rebuttal Expert…Concerning the Non- Infringement of U.S. Patent Nos. 9,089,587, 9,233,117 and 9,233,118 4) Rebuttal Expert…Concerning the Non- Infringement of U.S. Patent Nos. 9,089,587, 9,233,117, and 9,233,118 5) Expert Report…2017 12 March 2020 1:17-cv-01783 830 Patent Plaintiff District Court, D. Delaware | External link to document | |
| 2019-03-05 | 194 | Notice of Service | Ph.D. Concerning the Invalidity of U.S. Patent Nos. 9,089,587, 9,233,117, and 9,233,118; 2) Reply Expert…Rebecca Betensky, Ph.D. Concerning U.S. Patent Nos. 9,089,587, 9,233,117, and 9,233,118; and 4) Reply …Todd Plott, M.D. on the Invalidity of U.S. Patent Nos. 9,089,587, 9,233,117, and 9,233,118 filed by Teva …2017 12 March 2020 1:17-cv-01783 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| 2019-05-17 | 226 | Notice of Service | Ph.D. Concerning the Invalidity of U.S. Patent Nos. 9,089,587, 9,233,117 and 9,233,118 filed by Teva Pharmaceuticals…2017 12 March 2020 1:17-cv-01783 830 Patent Plaintiff District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
